Transgene Biotek Ltd
BSE:526139

Watchlist Manager
Transgene Biotek Ltd Logo
Transgene Biotek Ltd
BSE:526139
Watchlist
Price: 6.94 INR -6.34% Market Closed
Market Cap: 525.8m INR
Have any thoughts about
Transgene Biotek Ltd?
Write Note

P/OCF
Price to OCF

6 537.1
Current
6 075.5
Median
21.9
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
6 537.1
=
Market Cap
525.8m INR
/
Operating Cash Flow
80.4k INR
All Countries
Close
Market Cap P/OCF
IN
Transgene Biotek Ltd
BSE:526139
525.8m INR 6 537.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 640.8
US
Abbvie Inc
NYSE:ABBV
316.5B USD 19.3
US
Amgen Inc
NASDAQ:AMGN
141.2B USD 19.6
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.3B USD -124.9
US
Epizyme Inc
F:EPE
94.1B EUR -469.4
AU
CSL Ltd
ASX:CSL
135.7B AUD 30.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.2B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
36B EUR -144.9

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More